People Briefs: Changes At DexCom, Insulet, MITA And More
This article was originally published in The Gray Sheet
DexCom promotes Kevin Sayer to CEO post, while its diabetes collaborator Insulet makes multiple changes at the VP level. The Medical Imaging & Technology Alliance names policy director, and more.
You may also be interested in...
The insulin pump is the first FDA-approved device featuring Dexcom’s G4 Platinum sensing technology; it allows patients to see glucose data and administer insulin directly from the pump.
Glenmark hopes complex and respiratory products including a potential filing for generic Flovent pMDI can restore some lost sheen of its US business going forward, but a compliance comeback for its Monroe site may be pivotal to deliver material gains.
Embecta, which recently completed its spin-off from Becton Dickinson, is forging ahead with its insulin injector-based business strategy, GLP-1s be damned.